APO RESEARCH · REPORT
Sphingosine 1-Phosphate Receptor 1
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
Product & engineering
Understand the product.
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
Selected research
Industry Growth & Trends
Global Sphingosine 1-Phosphate Receptor 1 Industry Growth and Trends Forecast to 2032
Market perspective
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
In the last several years, global market of Sphingosine 1-Phosphate Receptor 1 developed rapidly, with an average growth rate of 3.5%, Sphingosine 1-Phosphate Receptor 1 is widely used in Hospital, Clinic. North America is the largest consumption place, with a revenue market share nearly 57.1% in 2019,. and market competition is not intense.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Sphingosine 1-Phosphate Receptor 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Sphingosine 1-Phosphate Receptor 1 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sphingosine 1-Phosphate Receptor 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sphingosine 1-Phosphate Receptor 1.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Sphingosine 1-Phosphate Receptor 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Sphingosine 1-Phosphate Receptor 1 Market by Company
Novartis AG
Bristol-Myers Squibb Company
Sphingosine 1-Phosphate Receptor 1 Segment by Type
Fingolimod
Siponimod
Ozanimod
Other
Sphingosine 1-Phosphate Receptor 1 Segment by Application
Hospital
Clinic
Other
Sphingosine 1-Phosphate Receptor 1 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sphingosine 1-Phosphate Receptor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sphingosine 1-Phosphate Receptor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sphingosine 1-Phosphate Receptor 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sphingosine 1-Phosphate Receptor 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Sphingosine 1-Phosphate Receptor 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fingolimod
- Siponimod
- Ozanimod
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Novartis AG
- Bristol-Myers Squibb Company
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Sphingosine 1-Phosphate Receptor 1 Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Estimates and Forecasts (2021-2032)
- 1.3 Sphingosine 1-Phosphate Receptor 1 Market by Type
- 1.3.1 Fingolimod
- 1.3.2 Siponimod
- 1.3.3 Ozanimod
- 1.3.4 Other
- 1.4 Global Sphingosine 1-Phosphate Receptor 1 Market Size by Type
- 1.4.1 Global Sphingosine 1-Phosphate Receptor 1 Market Size Overview by Type (2021-2032)
- 1.4.2 Global Sphingosine 1-Phosphate Receptor 1 Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Sphingosine 1-Phosphate Receptor 1 Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Sphingosine 1-Phosphate Receptor 1 Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Sphingosine 1-Phosphate Receptor 1 Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Sphingosine 1-Phosphate Receptor 1 Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Sphingosine 1-Phosphate Receptor 1 Industry Trends
- 2.2 Sphingosine 1-Phosphate Receptor 1 Industry Drivers
- 2.3 Sphingosine 1-Phosphate Receptor 1 Industry Opportunities and Challenges
- 2.4 Sphingosine 1-Phosphate Receptor 1 Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Sphingosine 1-Phosphate Receptor 1 Revenue (2021-2026)
- 3.2 Global Top Players by Sphingosine 1-Phosphate Receptor 1 Sales (2021-2026)
- 3.3 Global Top Players by Sphingosine 1-Phosphate Receptor 1 Price (2021-2026)
- 3.4 Global Sphingosine 1-Phosphate Receptor 1 Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sphingosine 1-Phosphate Receptor 1 Major Company Production Sites & Headquarters
- 3.6 Global Sphingosine 1-Phosphate Receptor 1 Company, Product Type & Application
- 3.7 Global Sphingosine 1-Phosphate Receptor 1 Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sphingosine 1-Phosphate Receptor 1 Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sphingosine 1-Phosphate Receptor 1 Players Market Share by Revenue in 2025
- 3.8.3 2025 Sphingosine 1-Phosphate Receptor 1 Tier 1, Tier 2, and Tier 3
4 Sphingosine 1-Phosphate Receptor 1 Regional Status and Outlook
- 4.1 Global Sphingosine 1-Phosphate Receptor 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Sphingosine 1-Phosphate Receptor 1 Historic Market Size by Region
- 4.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales in Volume by Region (2021-2026)
- 4.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales in Value by Region (2021-2026)
- 4.2.3 Global Sphingosine 1-Phosphate Receptor 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Sphingosine 1-Phosphate Receptor 1 Forecasted Market Size by Region
- 4.3.1 Global Sphingosine 1-Phosphate Receptor 1 Sales in Volume by Region (2027-2032)
- 4.3.2 Global Sphingosine 1-Phosphate Receptor 1 Sales in Value by Region (2027-2032)
- 4.3.3 Global Sphingosine 1-Phosphate Receptor 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sphingosine 1-Phosphate Receptor 1 by Application
- 5.1 Sphingosine 1-Phosphate Receptor 1 Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Sphingosine 1-Phosphate Receptor 1 Market Size by Application
- 5.2.1 Global Sphingosine 1-Phosphate Receptor 1 Market Size Overview by Application (2021-2032)
- 5.2.2 Global Sphingosine 1-Phosphate Receptor 1 Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Sphingosine 1-Phosphate Receptor 1 Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Sphingosine 1-Phosphate Receptor 1 Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Sphingosine 1-Phosphate Receptor 1 Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Sphingosine 1-Phosphate Receptor 1 Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Novartis AG
- 6.1.1 Novartis AG Company Information
- 6.1.2 Novartis AG Business Overview
- 6.1.3 Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Novartis AG Sphingosine 1-Phosphate Receptor 1 Product Portfolio
- 6.1.5 Novartis AG Recent Developments
- 6.2 Bristol-Myers Squibb Company
- 6.2.1 Bristol-Myers Squibb Company Company Information
- 6.2.2 Bristol-Myers Squibb Company Business Overview
- 6.2.3 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Product Portfolio
- 6.2.5 Bristol-Myers Squibb Company Recent Developments
7 North America by Country
- 7.1 North America Sphingosine 1-Phosphate Receptor 1 Sales by Country
- 7.1.1 North America Sphingosine 1-Phosphate Receptor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2026)
- 7.1.3 North America Sphingosine 1-Phosphate Receptor 1 Sales Forecast by Country (2027-2032)
- 7.2 North America Sphingosine 1-Phosphate Receptor 1 Market Size by Country
- 7.2.1 North America Sphingosine 1-Phosphate Receptor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Sphingosine 1-Phosphate Receptor 1 Market Size by Country (2021-2026)
- 7.2.3 North America Sphingosine 1-Phosphate Receptor 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Sphingosine 1-Phosphate Receptor 1 Sales by Country
- 8.1.1 Europe Sphingosine 1-Phosphate Receptor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2026)
- 8.1.3 Europe Sphingosine 1-Phosphate Receptor 1 Sales Forecast by Country (2027-2032)
- 8.2 Europe Sphingosine 1-Phosphate Receptor 1 Market Size by Country
- 8.2.1 Europe Sphingosine 1-Phosphate Receptor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Sphingosine 1-Phosphate Receptor 1 Market Size by Country (2021-2026)
- 8.2.3 Europe Sphingosine 1-Phosphate Receptor 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales by Country
- 9.1.1 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Market Size by Country
- 9.2.1 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Sphingosine 1-Phosphate Receptor 1 Sales by Country
- 10.1.1 South America Sphingosine 1-Phosphate Receptor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2026)
- 10.1.3 South America Sphingosine 1-Phosphate Receptor 1 Sales Forecast by Country (2027-2032)
- 10.2 South America Sphingosine 1-Phosphate Receptor 1 Market Size by Country
- 10.2.1 South America Sphingosine 1-Phosphate Receptor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Sphingosine 1-Phosphate Receptor 1 Market Size by Country (2021-2026)
- 10.2.3 South America Sphingosine 1-Phosphate Receptor 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales by Country
- 11.1.1 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Market Size by Country
- 11.2.1 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Sphingosine 1-Phosphate Receptor 1 Value Chain Analysis
- 12.1.1 Sphingosine 1-Phosphate Receptor 1 Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Sphingosine 1-Phosphate Receptor 1 Production Mode & Process
- 12.2 Sphingosine 1-Phosphate Receptor 1 Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Sphingosine 1-Phosphate Receptor 1 Distributors
- 12.2.3 Sphingosine 1-Phosphate Receptor 1 Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst